kin cancer is the most common cancer in Australia: over 250 000 people are diagnosed with non-melanoma skin cancer (NMSC) and over 8000 with melanoma annually.
1,2 This extremely high incidence makes skin cancer the most costly of all cancers to treat in Australia. 3, 4 Diagnosing skin cancer can be difficult. In primary care settings, sensitivity of clinical examination for diagnosing skin cancer has been reported to range from 40% to 80%. 5, 6 Diagnostic accuracy for pigmented lesions can be considerably lower. In one Australian study, the "number needed to treat" (ie, number of pigmented lesions excised for each confirmed melanoma) was reported to be about 29. 7 General practitioners in Australia provide primary care and act as gatekeepers to specialist services, traditionally diagnosing and managing most skin cancers without referral. 8, 9 This has changed recently, with the rapid emergence of "skin cancer medicine" as a subspecialty within primary care, particularly in Queensland. 10 This change has been controversial, mainly around issues such as diagnostic performance and appropriate management within skin cancer clinics. 11, 12 To date, only one small study of skin cancer clinics has examined diagnostic accuracy 13 and another has reported on billing data. 14 To address this gap in the evidence base, we undertook a prospective study of the casemix of patients with skin lesions presenting to primary care practitioners working in skin cancer clinics and in general practice. Focusing specifically on excised or biopsied skin lesions, our aim was to compare the diagnostic accuracy of clinicians working in the two settings. We did not address the issues of false negative results after a skin examination or of the adequacy of excision or recurrence of skin cancer after excision.
METHODS
Our study, conducted in 2005, involved mainstream GPs and skin cancer clinic doctors in south-eastern Queensland. Ethical approval was obtained from the Behavioural and Social Sciences Research Ethical Review Committee of the University of Queensland.
Selection of participants
GPs. Two hundred GPs in south-eastern Queensland were randomly selected from the Australasian Medical Publishing Company (AMPCo) database. They were sent a letter inviting participation in the study, an information sheet, a consent form and a reply-paid envelope. Non-responders received a reminder letter 2 weeks later, then a telephone call after a further 2 weeks if there was still no response.
Skin cancer clinic doctors. Using telephone listings, advertisements, the AMPCo database and the Internet, we identified 51 potentially suitable skin cancer clinics in the south-eastern Queensland area. Those eligible for our study were contacted using the same method as for GPs. Doctors working within skin cancer clinics are primarily vocationally trained GPs who have elected to subspecialise in skin cancer medicine, either in addition to or instead of general practice.
Data collection

Demographics of doctors
We collected data on age, sex, year of graduation, location of training, number of years worked in skin cancer clinics or as a GP, number of sessions per week, Royal Australian College of General Practitioners fellowship status, additional training in skin cancer (such as seminars, workshops, in-house courses within skin cancer clinics, dermoscopy courses), and equipment used to aid diagnosis (dermatoscopes, digital imaging).
Case-report forms
To ensure sufficient numbers of lesions for analysis, we collected data from GPs over two 8-week periods (a total of 16 weeks). As the volume of skin examinations within skin clinics was known to be higher than in general practice, 13 we collected data from skin cancer clinic doctors over two 4-week periods (a total of 8 weeks). Data were col- For analysis, clinical and histological diagnoses were categorised into broad groups: melanoma; basal cell carcinoma (BCC); squamous cell carcinoma (SCC), including intraepidermal carcinoma or Bowen' s disease (SCC-in-situ) and keratoacanthoma; solar keratosis; dysplastic naevus; benign naevus; other pigmented lesions (lentigines, ephelides and seborrhoeic keratosis); other benign lesions (skin tags, dermatofibroma, and cysts); and other malignant lesions. Where multiple diagnoses were recorded for a single lesion, malignant diagnoses were accorded pre-eminence over pre-malignant or benign diagnoses.
Analysis
We examined the frequencies of clinical and histological diagnoses and made standard bivariate comparisons between GPs and skin cancer clinic doctors. In our analysis of diagnostic accuracy, we included only those lesions for which both a clinical and a histological diagnosis (the latter being the "gold standard") were available (97.5% of all excisions or biopsies). We compared clinical with histological diagnoses separately for the major diagnostic groups, using measures including sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). 15 We also calculated the number needed to excise (NNE), defined as the ratio of all lesions (both benign and malignant) excised to the number of malignant lesions excised (see Box 1 for explanation of terms).
All analyses took into account the potentially changed variance associated with the sample design, specifically the possibility of correlation between assessments by the same clinician, and assessments by clinicians in the same practice. Logistic regression models were used to estimate each measure of diagnostic accuracy (Box 1). Initially, a constantonly logistic model was fitted, restricting it to either skin clinic doctors or GPs. The parameter estimate for the constant was then transformed (e ␤o /[1+e ␤o ]) to estimate the diagnostic accuracy for that doctor group. This is equivalent to fitting a risk difference model (using the identity link function).
An additional model (including both GP and skin cancer clinic doctors) with a variable indicating doctor type was then used to assess whether doctor type was significantly associated with diagnostic accuracy. Statistical significance was assumed at the 0.05 level. All analyses were performed using Stata statistical software, version 9.2 (StataCorp, College Station, Tex, USA).
RESULTS
Participation rates
Of the 200 GPs originally selected, seven were ineligible (four could not be traced, and three were no longer in practice). Of the remaining 193 eligible GPs, 39 refused, 47 did not respond and 107 consented. Three withdrew before data collection, leaving 104 participating GPs (54% of the original sample).
Of the 51 skin cancer clinics initially identified, 15 were ineligible for our study (four were no longer in business, nine were part of a general practice and two were staffed by dermatologists). Of the 36 remaining eligible clinics, six refused, one did not respond and two initially consented but withdrew before data collection. The final group consisted of 27 skin cancer clinics (75% participation rate), representing 50 doctors.
Demographics of doctors
There were no apparent differences in demographic or other characteristics between participating and non-participating skin cancer clinics or doctors, except female GPs were significantly more likely to participate than male GPs (P < 0.001).
Skin cancer clinic doctors were significantly younger, on average, than GPs (mean, 45 years v 50 years, respectively; P = 0.002); were predominantly male (84.0% in skin cancer clinics v 57.7% in general practice; P < 0.001); and were more likely to have undertaken additional training (including inhouse training) in skin cancer diagnosis (P < 0.001). Skin cancer clinic doctors worked fewer sessions per week -an average of 6.7 sessions (median, 7.0), compared with 8.0 sessions (median, 8.0) among GPs (P = 0.002). Compared with GPs, skin cancer clinic doctors were significantly more likely to use dermatoscopes (P < 0.001) and digitised imaging (P < 0.001) (Box 2).
Skin examinations
During the study period, GPs conducted 8790 skin examinations over a total of 1305.5 full-time equivalent (FTE) weeks (mean, 6.7 examinations per week). Skin cancer clinic doctors conducted 19 965 skin examinations over 236.5 FTE weeks (mean, 84.4 examinations per week). Patients of skin cancer clinics were more likely to be male than female and were younger, on average, than patients consulting GPs. Skin examina- 
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tions performed in skin cancer clinics were more likely to involve the whole body than those done by GPs (Box 3). For both GPs and skin cancer clinic doctors, the NNE for melanoma fell significantly with increasing confidence that the lesion was malignant (NNE for both groups combined was 4.1 for lesions rated "very likely to be malignant" compared with 98.9 for lesions "not at all likely to be malignant"). In over a third of cases in which the likelihood of malignancy was rated as nil or very low, patient insistence was cited as the main reason for excision. In recent years, there has been a significant increase in skin cancer-related procedures such as diagnostic biopsies and skin flap repairs. 4 The recent emergence of skin cancer clinics in primary care has provided an additional option for patients concerned about skin lesions, but questions have been raised about the clinical performance of doctors working in this area. 11, 12 To our knowledge, ours is the first large-scale prospective study to compare diagnostic accuracy between mainstream GPs and skin cancer clinic doctors. Our key finding was that diagnostic accuracy is similar for these two groups of doctors.
Skin lesions excised or biopsied
Strengths of our study were its large sample size, prospective design, random selection of GPs, and inclusion of a wide representation of skin cancer clinics. A limitation was the low response rate from GPs. While it was comparable to response rates in other studies auditing skin lesions, 7, 16 we can not be sure whether our sample was truly representative. Although we found no evidence of selection bias on the basis of age, sex or simple measures of clinical training, we had no information about the clinical interests of nonparticipating doctors, and so could not exclude the possibility that doctors with a particular interest in skin cancer medicine were over-represented among mainstream GP participants. There were no significant differences between participating and non-participating skin cancer clinics. While participants may have achieved increased diagnostic accuracy knowing that their performance was being scrutinised (the Hawthorne effect), 17 this effect would have been similar for both groups.
Further, it is possible that patients attending general practices differ from those attending skin cancer clinics in ways that may affect diagnostic accuracy. For example, if patients in either setting are at higher risk of any skin cancer or of melanoma, a higher sensitivity and specificity for diagnosis of these cancers would be expected.
We observed that the average number of skin examinations, excisions and biopsies carried out by GPs in our study was similar to the number performed in previous studies in similar settings. 5, 18, 19 Further, in our study, the distribution of histological diagnoses of lesions in both general practice and skin cancer clinics was similar (46% of lesions in general practice and 50% of those in skin cancer clinics were NMSC). These figures were also comparable to those of other studies. 5, 20 Our results are consistent with previous studies of diagnostic accuracy in skin cancer. 7, 21 Our finding that whole-body skin examinations were more common in skin cancer clinics than in general practice is significant, given the importance of early detection of melanoma. Melanoma detection rates can be improved sixfold by examining the whole body rather than just a part of it. 22 We found that sensitivity for diagnosis of melanoma was significantly higher in skin cancer clinic doctors than in GPs. Skin cancer clinic doctors identified 60% of melanomas clinically, which was similar to the detection rate in one previous Australian study 16 and higher than the detection rate in an overseas study. 23 The PPV for melanoma was relatively low for both GPs (0.18) and skin cancer clinic doctors (0.25). However, this is not surprising, as doctors tend to be cautious in diagnosing melanoma, preferring to risk excising a benign lesion than to miss a potentially fatal cancer. 24, 25 About 30% of histologically confirmed melanomas were given a clinical diagnosis of dysplastic naevus.
The sensitivity of a diagnosis of malignancy was very high for doctors in both settings (0.91 for GPs and 0.94 for skin cancer clinic doctors) and did not alter after adjusting for years of clinical experience. Overall, about 70% of lesions diagnosed clinically as malignant were found to be malignant on histology (ie, the PPV was fairly high).
These results are similar to those found in other Australian studies, 5, 13, 20 and higher than reason for consultation. ** Skin examination was not primary reason for consultation. † † Distribution of degree of patient pressure to excise was based on all excised or biopsied lesions less those that were re-excised (n = 93).
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studies in countries where skin cancer incidence is lower. 6, 26 One interpretation is that Australian GPs develop good diagnostic skills given the high incidence of skin cancer. Similar positive correlations with increased caseloads have been reported for other diagnostic and surgical procedures. 27, 28 Additionally we found that, for both groups, the NPV was very high (0.92) for lesions that the doctor gave a low to very low likelihood of malignancy.
We found no significant differences between GPs and skin cancer clinic doctors regarding the number of lesions excised per malignancy. Moreover, the number of pigmented lesions excised per melanoma (21 for GPs versus 19 for skin cancer clinic doctors) was similar to the number found in previous studies (showing NNEs in the order of 22-29). 7, 21 The question arises as to whether doctors should aim for a high NNE (increasing the number of benign lesions excised) or a low NNE (increasing the risk that some melanomas will be missed). A number of factors can influence the decision of whether to excise a pigmented lesion. In our study we found that the number of lesions excised per melanoma fell as confidence in the likelihood of malignancy increased. We also found that a proportion of clearly benign lesions were excised after patient insistence, as reported by others. 29 In conclusion, we found that doctors in both primary care settings (mainstream general practice and skin cancer clinics), achieved high sensitivity and specificity for diagnosing NMSC. Although skin cancer clinic doctors achieved significantly higher sensitivity for diagnosing melanoma, this was based on a small number of melanomas. Specificity for diagnosing melanoma and overall clinical accuracy for diagnosing skin cancer was similar between the two groups. These findings provide large-scale data to address the question of diagnostic accuracy of excised skin lesions within a rapidly growing area of primary care. However, the question of what clinical and patient-related factors influence decisions about management of suspicious skin lesions in the primary care setting is still to be answered. 
